2019 annual financial data
Axsome Therapeutics 2019 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -67,245,097 USD and net income was -68,345,186 USD.
Operating cash flow was -46,375,059 USD.
Get free Axsome Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -67,245,097 USD
- Net income
- -68,345,186 USD
- Operating cash flow
- -46,375,059 USD